Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Japan
MedTech
Japan greenlights Sysmex's amyloid blood test for Alzheimer's
Sysmex received approval within the country for a two-step test kit that gauges the ratio between two beta amyloid proteins in the bloodstream.
Conor Hale
Dec 22, 2022 10:30am
Canon doubles down on US presence with new $300M subsidiary
Nov 29, 2022 1:11pm
MEI, Kyowa confirm phase 2 cancer efficacy with fresh data drop
Nov 18, 2022 9:35am
SoftBank to bring Pear’s digital insomnia therapeutics to Japan
Mar 21, 2022 10:17am
Shionogi files for approval of oral COVID-19 antiviral in Japan
Feb 25, 2022 7:01am
Casio scores FDA clearance for dermatology camera system
Feb 16, 2022 10:20am
